• Explore /
  • Poster
  • / Efficacy of enzalutamide (ENZA) + androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC) by pattern of metastatic spread: ARCHES <em>post hoc</em> analyses.

Efficacy of enzalutamide (ENZA) + androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC) by pattern of metastatic spread: ARCHES post hoc analyses.

Abstract Video & Slides Poster

Authors

null

Neal D. Shore

Carolina Urologic Research Center, Myrtle Beach, SC

Neal D. Shore , Andrew J. Armstrong , Russell Zelig Szmulewitz , Daniel Peter Petrylak , Jeffrey Holzbeierlein , Arnauld Villers , Arun Azad , Antonio Alcaraz , Boris Alekseev , Taro Iguchi , Francisco Gomez-Veiga , Brad Rosbrook , Ho-Jin Lee , Gabriel P. Haas , Arnulf Stenzl

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02677896

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5547)

DOI

10.1200/JCO.2020.38.15_suppl.5547

Abstract #

5547

Poster Bd #

128

Abstract Disclosures

Similar Posters

First Author: Andrew J. Armstrong

First Author: Arun Azad

Poster

2024 ASCO Genitourinary Cancers Symposium

Clinical and patient factors associated with treatment intensification for metastatic castration-sensitive prostate cancer.

Clinical and patient factors associated with treatment intensification for metastatic castration-sensitive prostate cancer.

First Author: Sreevalsa Appukkuttan

First Author: Susan Halabi